CCNE1 and cancer: Abnormal expression of cyclin E was detected in various high-grade malignant cells (47–51), which is a key link in the chemotherapy resistance mechanism of various tumor cells and may be used as a potential treatment target to reverse or reduce antitumor drug resistance in cancer therapy (52).